Amniotic fluid embolism (AFE) is a rare but potentially lethal condition characterized by an abrupt onset, unpredictability, and high fatality rate. The Society for Maternal-Fetal Medicine (SMFM) published clinical guideline No. 9 “Amniotic fluid embolism: diagnosis and management” in 2016. Based on this guideline and other relevant studies, the Obstetrics Group of the Chinese Society of Obstetrics and Gynecology, Chinese Medical Association, developed a consensus on the diagnosis and treatment of AFE in December 2018, aiming to standardize its diagnosis and management, and to improve maternal and perinatal outcomes.
展开▼